498 related articles for article (PubMed ID: 32883070)
21. Intracellular glutathione-depleting polymeric micelles for cisplatin prodrug delivery to overcome cisplatin resistance of cancers.
Han Y; Yin W; Li J; Zhao H; Zha Z; Ke W; Wang Y; He C; Ge Z
J Control Release; 2018 Mar; 273():30-39. PubMed ID: 29371047
[TBL] [Abstract][Full Text] [Related]
22. Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine.
Hong Y; Che S; Hui B; Wang X; Zhang X; Ma H
Drug Des Devel Ther; 2020; 14():2263-2274. PubMed ID: 32606596
[TBL] [Abstract][Full Text] [Related]
23. Fabricating nanoparticles co-loaded with survivin siRNA and Pt(IV) prodrug for the treatment of platinum-resistant lung cancer.
Ma S; Li X; Ran M; Ji M; Gou J; Yin T; He H; Wang Y; Zhang Y; Tang X
Int J Pharm; 2021 May; 601():120577. PubMed ID: 33839227
[TBL] [Abstract][Full Text] [Related]
24. Mitochondria-Targeted BODIPY Nanoparticles for Enhanced Photothermal and Photoacoustic Imaging In Vivo.
Wang JL; Zhang L; Zhao MJ; Zhang T; Liu Y; Jiang FL
ACS Appl Bio Mater; 2021 Feb; 4(2):1760-1770. PubMed ID: 35014522
[TBL] [Abstract][Full Text] [Related]
25. Alternative mechanism of action of the DNP Pt
Krasnovskaya O; Spector D; Erofeev A; Gorelkin P; Akasov R; Skvortsov D; Trigub A; Vlasova K; Semkina A; Zyk N; Beloglazkina E; Majouga A
Dalton Trans; 2021 Jun; 50(23):7922-7927. PubMed ID: 34037020
[TBL] [Abstract][Full Text] [Related]
26. Peptide-Based Autophagic Gene and Cisplatin Co-delivery Systems Enable Improved Chemotherapy Resistance.
Lin YX; Wang Y; An HW; Qi B; Wang J; Wang L; Shi J; Mei L; Wang H
Nano Lett; 2019 May; 19(5):2968-2978. PubMed ID: 30924343
[TBL] [Abstract][Full Text] [Related]
27. Reduction-sensitive platinum (IV)-prodrug nano-sensitizer with an ultra-high drug loading for efficient chemo-radiotherapy of Pt-resistant cervical cancer in vivo.
Luo K; Guo W; Yu Y; Xu S; Zhou M; Xiang K; Niu K; Zhu X; Zhu G; An Z; Yu Q; Gan Z
J Control Release; 2020 Oct; 326():25-37. PubMed ID: 32531414
[TBL] [Abstract][Full Text] [Related]
28. NIR-Light-Triggered Mild-Temperature Hyperthermia to Overcome the Cascade Cisplatin Resistance for Improved Resistant Tumor Therapy.
Chen M; Fu Y; Liu Y; Zhang B; Song X; Chen X; Zhu Z; Gao H; Yang J; Shi X
Adv Healthc Mater; 2024 Apr; 13(11):e2303667. PubMed ID: 38178648
[TBL] [Abstract][Full Text] [Related]
29. Carboplatin prodrug conjugated Fe
Song H; Quan F; Yu Z; Zheng M; Ma Y; Xiao H; Ding F
J Mater Chem B; 2019 Jan; 7(3):433-442. PubMed ID: 32254730
[TBL] [Abstract][Full Text] [Related]
30. Redirecting Cisplatin and Doxorubicin to Mitochondria Affords Highly Effective Platinum
Muhammad N; Cai-Ping T; Nasreen S; Mao ZW
Chem Asian J; 2021 Aug; 16(16):2276-2279. PubMed ID: 34231967
[TBL] [Abstract][Full Text] [Related]
31. Cisplatin resistance reversal in lung cancer by tumor acidity-activable vesicular nanoreactors via tumor oxidative stress amplification.
Mukerabigwi JF; Han Y; Lu N; Ke W; Wang Y; Zhou Q; Mohammed F; Ibrahim A; Zheng B; Ge Z
J Mater Chem B; 2021 Apr; 9(13):3055-3067. PubMed ID: 33885667
[TBL] [Abstract][Full Text] [Related]
32. Self-assembled albumin nanoparticles for combination therapy in prostate cancer.
Lian H; Wu J; Hu Y; Guo H
Int J Nanomedicine; 2017; 12():7777-7787. PubMed ID: 29123392
[TBL] [Abstract][Full Text] [Related]
33. Corrosion-Activated Chemotherapeutic Function of Nanoparticulate Platinum as a Cisplatin Resistance-Overcoming Prodrug with Limited Autophagy Induction.
Cheng HJ; Wu TH; Chien CT; Tu HW; Cha TS; Lin SY
Small; 2016 Nov; 12(44):6124-6133. PubMed ID: 27717137
[TBL] [Abstract][Full Text] [Related]
34. Delivery of Platinum(IV) Prodrugs via Bi
Ma Y; Zhang DY; Peng Z; Guan S; Zhai J
Mol Pharm; 2020 Sep; 17(9):3403-3411. PubMed ID: 32692573
[TBL] [Abstract][Full Text] [Related]
35. Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo.
Ma ZY; Wang DB; Song XQ; Wu YG; Chen Q; Zhao CL; Li JY; Cheng SH; Xu JY
Eur J Med Chem; 2018 Sep; 157():1292-1299. PubMed ID: 30195239
[TBL] [Abstract][Full Text] [Related]
36. Light-activatable dual prodrug polymer nanoparticle for precise synergistic chemotherapy guided by drug-mediated computed tomography imaging.
Wang Z; Kuang G; Yu Z; Li A; Zhou D; Huang Y
Acta Biomater; 2019 Aug; 94():459-468. PubMed ID: 31128323
[TBL] [Abstract][Full Text] [Related]
37. Internal cross-linked polymeric nanoparticles with dual sensitivity for combination therapy of muscle-invasive bladder cancer.
Zhu G; Wang K; Qin H; Zhao X; Chen W; Xu L; Cao W; Guo H
J Nanobiotechnology; 2020 Sep; 18(1):124. PubMed ID: 32887622
[TBL] [Abstract][Full Text] [Related]
38. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
39. A red-light activatable and mitochondrion-targeting Pt
Li Y; Wang Z; Qi Y; Tang Z; Li X; Huang Y
Chem Commun (Camb); 2022 Jul; 58(60):8404-8407. PubMed ID: 35796077
[TBL] [Abstract][Full Text] [Related]
40. Design and construction of IR780- and EGCG-based and mitochondrial targeting nanoparticles and their application in tumor chemo-phototherapy.
Bao J; Zhao Y; Xu J; Guo Y
J Mater Chem B; 2021 Dec; 9(48):9932-9945. PubMed ID: 34842269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]